## LKQ: LKQ Corporation - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 1.06 indicates fundamental undervaluation. Consistent execution (3/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($27.31)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-12 | Barclays | $33 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-12 | Barclays | init | Equal-Weight |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 47.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 11.9% (-0.9%)
- Blackrock Inc.: 6.5% (-27.6%)
- Morgan Stanley: 5.2% (-20.0%)
- Nordea Investment Ma: 5.0% (+3.2%)
- Massachusetts Financ: 4.5% (+5.2%)

### Key Risks

1. Long-term trend broken: trading 18.8% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.06 suggests fair value with growth premium. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $7.4B |
| Beta | 0.90 |
| 52W Range | $28.42 - $44.82 |
| Short Interest | 6.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.06 |
| Forward P/E | 8.7 |
| Current P/E | 9.3 |
| YoY Growth | 6.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 weakening modestly (-0.5% over 5 days). Below STRENGTH zone by 9.0pp (needs >4.0% for momentum thesis). Underperforming sector by 4.2pp, stock-specific weakness. Below SMA200 (0.81x), long-term trend not supportive. RSI neutral at 42.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -4.96% (CS: 15) | Weak |
| RSI_14 | 41.8 | Neutral |
| MACD Histogram | -0.05 | Bearish |
| vs SMA20 | 0.969x | Below |
| vs SMA50 | 0.957x | Below |
| vs SMA200 | 0.812x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $28.87
- **Stop Loss:** $27.31 (5.4% risk)
- **Target:** $31.99 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 320
- **Position Value:** $9,238.40
- **Portfolio %:** 9.24%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-02-19 (Est: $0.65)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.76 | $0.84 | +11.0% |
| 2025Q2 | $0.92 | $0.87 | -5.8% |
| 2025Q1 | $0.78 | $0.79 | +1.5% |
| 2024Q4 | $0.74 | $0.80 | +7.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*